TY - JOUR
T1 - Fluoxetine administered to juvenile monkeys
T2 - Effects on the serotonin transporter and behavior
AU - Shrestha, Stal Saurav
AU - Nelson, Eric E.
AU - Liow, Jeih San
AU - Gladding, Robert
AU - Lyoo, Chul Hyoung
AU - Noble, Pam L.
AU - Morse, Cheryl
AU - Henter, Ioline D.
AU - Kruger, Jeremy
AU - Zhang, Bo
AU - Suomi, Stephen J.
AU - Svenningsson, Per
AU - Pike, Victor W.
AU - Winslow, James T.
AU - Leibenluft, Ellen
AU - Pine, Daniel S.
AU - Innis, Robert B.
PY - 2014/3/1
Y1 - 2014/3/1
N2 - Objective: This study examined the longterm effects of fluoxetine administered to juvenile rhesus monkeys who, as young adults, were imaged with positron emission tomography for two serotonergic markers: Serotonin transporter (SERT) and serotonin 1A (5-HT1A) receptor. An equal number of monkeys separated from their mothers at birth-an animal model of human childhood stress-were also studied. Method: At birth, 32 male rhesus monkeys were randomly assigned to either maternal separation or normal rearing conditions. At age 2, half (N=8) of each group was randomly assigned to fluoxetine (3 mg/kg) or placebo for 1 year. To eliminate the confounding effects of residual drug in the brain, monkeys were scanned at least 1.5 years after drug discontinuation. Social interactions were assessed both during and after drug administration. Results: Fluoxetine persistently upregulated SERT, but not 5-HT1A receptors, in both the neocortex and the hippocampus. Whole-brain voxel-wise analysis revealed that fluoxetine had a significant effect in the lateral temporal and cingulate cortices. In contrast, neither maternal separation by itself nor the rearing-by-drug interaction was significant for either marker. Fluoxetine had no significant effect on the behavioral measures. Conclusions: Fluoxetine administered to juvenile monkeys upregulates SERT into young adulthood. Implications regarding the efficacy or potential adverse effects of SSRIs in patients cannot be directly drawn from this study. Its purpose was to investigate effects of SSRIs on brain development in nonhuman primates using an experimental approach that randomly assigned long-term SSRI treatment or placebo.
AB - Objective: This study examined the longterm effects of fluoxetine administered to juvenile rhesus monkeys who, as young adults, were imaged with positron emission tomography for two serotonergic markers: Serotonin transporter (SERT) and serotonin 1A (5-HT1A) receptor. An equal number of monkeys separated from their mothers at birth-an animal model of human childhood stress-were also studied. Method: At birth, 32 male rhesus monkeys were randomly assigned to either maternal separation or normal rearing conditions. At age 2, half (N=8) of each group was randomly assigned to fluoxetine (3 mg/kg) or placebo for 1 year. To eliminate the confounding effects of residual drug in the brain, monkeys were scanned at least 1.5 years after drug discontinuation. Social interactions were assessed both during and after drug administration. Results: Fluoxetine persistently upregulated SERT, but not 5-HT1A receptors, in both the neocortex and the hippocampus. Whole-brain voxel-wise analysis revealed that fluoxetine had a significant effect in the lateral temporal and cingulate cortices. In contrast, neither maternal separation by itself nor the rearing-by-drug interaction was significant for either marker. Fluoxetine had no significant effect on the behavioral measures. Conclusions: Fluoxetine administered to juvenile monkeys upregulates SERT into young adulthood. Implications regarding the efficacy or potential adverse effects of SSRIs in patients cannot be directly drawn from this study. Its purpose was to investigate effects of SSRIs on brain development in nonhuman primates using an experimental approach that randomly assigned long-term SSRI treatment or placebo.
UR - http://www.scopus.com/inward/record.url?scp=84894284825&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894284825&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.2013.13020183
DO - 10.1176/appi.ajp.2013.13020183
M3 - Article
C2 - 24480874
AN - SCOPUS:84894284825
SN - 0002-953X
VL - 171
SP - 323
EP - 331
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 3
ER -